(Q36660533)
Statements
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (English)
George Blumenschein
John Sarantopoulos
Howard Kallender
Harold N Keer
24 August 2012
24 August 2012
1 reference
1 reference
1 reference
1 reference
1 reference